This medicine has been identified as being suitable for inclusion on the Amber List of specialist medicines.
The shared care arrangements for warfarin are managed through Trust and HSCB policies and guidelines rather than a regional SCG. The Regional Group on Specialist Medicines have determined that a regional shared care guideline is not required for this medicine, but that local arrangements for shared care should apply.